Researchers at WashU Medicine have harnessed the internal circadian clock of the body to deliver medication for an ...

Vamorolone showed promising results to effectively treat inflammation whilst minimising negative side compared to current ...

"If you've had rheumatoid arthritis for that long ... the path from animal studies to human trials may be shorter than it would be for a brand-new drug. The next steps toward human patients largely ...

Pfizer has received approval from the US FDA for its rheumatoid arthritis (RA) drug, Xeljanz, which is the first approved RA treatment in a new class of medicines known as Janus kinase inhibitors ...

Adverse events from disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis decline by as much as 25% after the drugs are established on the market, according to data published ...

Professor John Isaacs is leading a study which hopes to cure rheumatoid arthritis - he has shared the 'pioneering' project and revealed its numerous benefits for patients ...

Infliximab works by blocking a molecule called tumor necrosis factor (TNF), which is a major part of the body’s immune ...

Long-term infliximab use in rheumatoid arthritis patients may reduce the risk of cervical spine deformity, new research ...